Breakoutwatch Weekly Summary 10/09/2023

You are receiving this email because you are or were a BreakoutWatch.com subscriber, or have subscribed to our weekly newsletter.
To read this newsletter on the site, click here: Newsletter .

Contents

The newsletter has been absent for a few weeks as I have concentrated on correcting some data problems introduced by a hack of the database. I believe all stock data is now correct and watchlist filters are working again. Next week I depart for 4 weeks on a European vacation but will try to produce this newsletter remotely.

Market Summary

Stocks end the week mixed following Friday’s surprise jobs data

The major indexes closed mixed over another week of top-heavy trading in which large-cap growth stocks—and the mega-cap information technology and internet stocks, in particular—widely outpaced the rest of the market. Reflecting the underperformance of most stocks, an equally weighted version of the S&P 500 Index lagged its market-weighted counterpart by the largest margin since March. Similarly, large-cap growth stocks outperformed their value counterparts (according to Russell indexes) and the large-cap S&P 500 outperformed the small-cap Russell 2000 Index by the widest margins over the same period. [more...]

Major Index Performance

Dow Jones
Last Close 33407.6
Wk. Gain -0.14 %
Yr. Gain 0.78 %
Trend Down
Dow Jones
S&P 500
Last Close 4308.5
Wk. Gain 0.56 %
Yr. Gain 11.81 %
Trend Down
S&P 500
NASDAQ Comp.
Last Close 13431.3
Wk. Gain 1.61 %
Yr. Gain 27.17 %
Trend Down
NASDAQ Comp.
Russell 2000
Last Close 13431.3
Wk. Gain 677.68 %
Yr. Gain 626.92 %
Trend Down
Russell 2000

Performance by Sector

Sector Wk. Change % Yr. Change % Trend
Consumer Discretionary -0.36 22.72 Down
Consumer Staples -3.04 -8.05 Down
Energy -5.19 0.25 Down
Finance -0.29 -3.02 Down
Health Care 0.85 -4.45 Down
Industrials -0.36 6.37 Down
Technology 2.17 34.14 Down
Materials -0.84 0.19 Down
REIT -1.45 -9.89 Down
Telecom 1.72 31.97 Down
Utilities -2.29 -20 Down

Breakouts This Week Still Within 5% of Breakout Price (Limit 20 top C Score)

Watchlist Symbol Company Industry C Score* % Gain
*C score is our assessment of a Stock's correlation to CAN SLIM principles. It combines a stock's Technical and Fundamental merits and is expressed as a percentage.

Breakdowns within 5% of Breakdown Price

Watchlist Symbol Company Industry C Score* % Loss
There were no Breakdowns still within 5% of breakdown price this week
*C score is our assessment of a Stock's correlation to CAN SLIM principles. It combines a stock's Technical and Fundamental merits and is expressed as a percentage.

Cup and Handle Chart of the Week

Aug. 16, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the achievement of First-Patient-In for the company-sponsored Phase 2 clinical trial evaluating darovasertib as neoadjuvant and adjuvant therapy in primary uveal melanoma (UM) patients.